Enzon Pharmaceuticals, Inc. is focused on leveraging its position as a public company to serve as an acquisition platform, aiming to enhance stockholder value while utilizing its net operating loss carryforwards. This strategic approach allows the company to explore potential acquisitions that can complement its existing operations and drive growth.

In terms of its product pipeline, Enzon Pharmaceuticals emphasizes the development of innovative therapies, particularly in the field of oncology and rare diseases. The company is committed to advancing its scientific capabilities and exploring new technologies that can lead to effective treatments, thereby addressing unmet medical needs and improving patient outcomes.

United States

Enzon is a New Jersey-based biopharmaceutical company that develops and commercializes medicines for the treatment of cancer.

Enzon Pharmaceuticals

Company Details